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Resource Modelling for the QC Laboratory at XYZ
Pharmaceuticals in Southern Africa
N.P. Munhuweyi 1, Z. Ekeocha 2, S. Byrn 3, K. Clase 4

ABSTRACT
Quality control (QC) laboratories are critical components in drug manufacturing and running them efficiently
contributes to better, consistent supply of cost-effective quality products, while also and preventing deaths due to
untimely delivery or unavailability of medicines. Having a resource modelling tool to estimate resources needed to
handle a particular demand in a given system is essential for efficient running of QC laboratory.
This study was done to establish such a model at XYZ Pharmaceuticals. The list of all products manufactured by
XYZ Pharmaceuticals Southern Africa was reviewed; and product families for all products were identified.
Analysts ’hands on time (HOT) to process one sample of each of the product families was estimated.
The number of analysts required to support the workload at XYZ Pharmaceuticals was calculated using the HOTs
for the different product families and the Maslaton’s Calculation Model. A baseline resource model was
established.
Keywords: hands on time (HOT), quality control (QC) laboratory, Lean Six Sigma, scheduling, planning,
modelling

1. INTRODUCTION
Pharmaceutical manufacturers continue to operate in
an increasingly competitive environment, contending
with issues that run the range from lost revenue from
expired patents, ballooning costs for new drug
research and development, changes required by new
regulations and other compliance mandates and
global market pressures to reduce costs and improve
quality and delivery (May, 2014).
The quality control (QC) laboratory plays a critical role
in pharmaceutical production for both in-process and
finished product testing. Laboratories not only monitor
and control the quality of incoming APIs (active
pharmaceutical ingredients), and other supplies used
in the manufacturing process, but QC labs are also
instrumental in the batch release process (May,
2014). They also have to follow strict regulatory

guidelines (Lopes, Costigliola, Pinto, Vieira, & Sousa,
2018).
QC laboratories (labs) are a critical component in the
manufacturing value stream for pharmaceutical
products. However, lab environments are unique, as
they possess their own special characteristics. They
are hybrid, sharing many aspects of both service
operations and manufacturing.
QC laboratories are responsible for quality, safety and
efficacy of new medicines, and their management is a
complex task that involves resource planning and
scheduling,
analysis
prioritization,
results
documentation, etc. Inefficiencies at the laboratory
level may delay obtaining results, negatively affect
their quality and can have a major impact on the
overall supply chain service level. This situation can
be worse in cases where contract manufacturing or
testing is done, where the organization has to deal
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with a large number of projects (Costigliola, Ataíde,
Vieira & Sousa, 2017).
Significant attention needs to be paid to compliance,
GLPs and safety. Equipment is often very expensive,
highly sophisticated, extremely sensitive and requires
proper operating and maintenance to avoid
equipment breakdowns. QC laboratories serve as
internal
suppliers
to
the
pharmaceutical
manufacturing departments, but unlike many service
operations, their processes and “products”, i.e. timely
test results, are mostly intangible and invisible in
comparison with those of manufactured goods. (May,
2014).
Finding an optimum balance between staff time and
machine time is of utmost importance in the lab, as is
standardizing work to ensure that procedures are
adhered to. It is common across pharmaceutical
companies globally to find laboratory analysts and
managers continually struggling with:
•

being reactive at all times to the pressure
of the workload, unable to pro-actively
schedule activities on their terms.

•

variable demand and uneven workloads;

•

complex scheduling that combines
routine testing with special tests and
projects;

•

large backlogs and missed deadlines,
which trigger fast-tracking or expediting
of work and further complicate
scheduling;

•

Individuals who are inflexible and have
difficulty working in an environment that
changes frequently. (May, 2014)

Such is the case at XYZ Pharmaceuticals, where
analysts’ schedules are driven by the demand and are
always chasing after deadlines and lack real control
of the system’s pace. The nature of the demand and
how it matches with resources has not been broken
down and analyzed. Supervisors have been asked
many times by management to determine how many
analysts they need to match their workload but always
have difficulty justifying the numbers they come up
with. Therefore, even though operations are not
happening in a worst-case scenario, where there is no
vision at all, the existing vision is unclear. What is
lacking is the visual understanding and the
quantification of the demand. Also lacking, is a clear
and precise visualization of the demand matches with
resources, in addition to finding a better way to
effectively manage flow and scheduling.

As a result, steady pressure is on supervisors to
improve QC lab operations. In general, the challenges
can be described as follows: finding a way to improve
capacity and utilization of resources, reducing lead
times while increasing reliability and speeding up the
authorizations required for compliance, for both
production and batch release (May, 2014).
Since problems in the QC laboratory are similar for
pharmaceutical companies, many articles have been
written on methods to increase efficiencies in the QC
laboratory and enable QC management to have better
control of the pace of operations. The research
generally highlights the importance of being able to
frame the problem and identify the causes before
formulating solutions.
A management policy, Lean Six Sigma that explores
improving the quality of process outputs by analyzing
and abolishing the source of defects/errors and
reducing variability in manufacturing and business
practices is being used widely in QC labs. It is used to
reduce the existing errors or mistakes in terms of
defects per million (DPM). Furthermore, it improves
the quality and efficiency of operational processes.
Six Sigma essentially aims to make operations more
reliable and accurate through the utilization of
statistical methods (Vijayshri, Pranil, Lakhe, Jaju, &
Deshmukh, 2017).
Lean Six Sigma (lean) thinking provides useful ways
to address the challenge. However, while Lean Six
Sigma has been used extensively in many process
manufacturing industries, laboratories have lagged
behind in applying Lean Six Sigma principles;
however, they are starting to catch up. Many of these
same principles can work in virtually any laboratory
environment, including medical and clinical
laboratories, as well as laboratories in other types of
chemical manufacturing (Costigliola et al., 2017).
May (2014) highlighted the importance of establishing
stability first in the lab processing using the 5s
techniques (i.e. sort, set in order, shine, standardize,
and sustain). The processes would then be linked in
a flow diagram and the workload managed visually
(May, 2014). Grovom (2013) highlighted how 5s is a
foundation of lean. He emphasized determining
needed equipment and procedures using 5s
techniques. The same techniques can also be applied
to determining needed human resources, i.e.
analysts. 5s is capable of valuable improvements in
pharmaceutical QC laboratories as demonstrated in
other industrial labs. When 5s was rolled out at Roche
Carolina QC Lab, it was noted how it could change
culture in the laboratory by reducing wasteful habits,
while benefiting inefficient and unorganized lab
schedules, plans and systems (Grovom, 2013).
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It was shown that for lean to be applied effectively in
the QC laboratory environment, a good understanding
of the lab functions is required. Functions to be
considered include the context of the pharmaceutical
manufacturing value stream, the work culture in a
specific laboratory and company environment, and of
how lean is applied in both manufacturing and service
environments. When used effectively, lean principles
can yield enormous productivity improvements in QC
labs, improvements that are sorely needed in the
current global pharmaceutical environment (May,
2014).
A project to test the effectiveness of lean principles
was conducted at a QC laboratory of a global
manufacturing company Pfizer, in Puurs, Belgium. Of
note, their methodology showed that to conduct a
study in the lab, it was not necessary to perform timeconsuming studies on all products. Instead, a few
products could be selected and the data could be
extrapolated to make a model that could be used at
different sites. The lab conducted inventory of only
eight high-volume products using Kaizen principles to
define, measure, analyze, improve and control
methodology to analyze its value stream. They
recognized that throughput improvements for the
eight high‐volume products they had used were
also applicable to the remaining products (DeWit,
2011).
Costigliola et al. (2017) perfomed a study where the
main objectives were to come up with a standard
model to measure performance of a QC laboratory.
Information from the model then acted as a support
tool for planning, scheduling and decision-making. He
realized that all the stakeholders of a QC laboratory
would primarily want to be able to estimate equipment
and labour utilization, in addition to time needed to
estimate an analysis. Initially, he had to understand
the flow of products and information in the system. A
work measurement and time study was then done
over a period of one month by completing manual
forms to estimate time taken for sample preparation,
system setup, equipment cleaning and analysis data
processing. Equipment hands-on tasks were
separated from the hands-off tasks. The critical
metrics in the study were throughput, equipment
usage rate and employee utilization (Costigliola et al.,
2017).
Consultants from Tefen management indicated that a
pharmaceutical QC laboratory would be more efficient
by making the system lean through the following
processes: identifying the value stream, gap analysis,
elimination of waste, planning and control and, finally,
continuous improvement (Tefen, n.d.) Rapid Micro
Biosystems also recommended a similar approach
starting with mapping out the value system,

eliminating waste and improving the process (Rapid
Micro Biosystems, 2014).
Harte (2018) initially encouraged establishing the lean
goals by doing pareto analysis to identify products
contributing to much of the workload and value stream
maps. Lab performance was measured and cycle
time was identified as an important metric. After
analyzing the data, ways of improving performance
were then identified (Harte, 2018).
According to Schäfer (2004), workflows needed to be
identified first before engaging automated systems,
which made scheduling easier. Maslaton (2012b)
agreed that automating the schedule allowed the
supervisor more time for other tasks that his/her role
calls for, such as managing investigations, conducting
audit trail review, leading root cause analyses,
training the analysts, etc. Scheduling is also important
in the laboratory to ensure efficiency. Scheduling is
often done and left to the supervisors ’experience.
Laboratory information management systems (LIMS)
used by pharmaceutical companies only track the
analyses performed and lack some features (i.e.
information on processing times, work flow) essential
for planning, scheduling and stock management.
Advances in informatics, data analysis and
knowledge management made industries aware of
the power of information. This information can be
organized and generate knowledge to improve the
quality of the services and manufacturing processes.
As a result, informatics is often being incorporated in
the industrial setting. Industrial informatics represents
an important field of study.Informatics is now not only
related to Information Technology (IT) services and
infrastructure, but is also used to design, simulate,
and model manufacturing processes. (Costigliola et
al., 2017).
The importance of resource planning in QC labs to
meet both capacity and compliance is well
recognized. However, Maslaton (2012b) focused on
lab scheduling as the single most important process
in the QC lab since scheduling contributes to all
aspect of lab operation efficiency. He felt scheduling
was the single most important process in the QC labs,
as it contributes to all aspects of the lab operation
efficiency. Most of the labs today are using
whiteboard and Microsoft Excel-based tools, while
using LIMS to define the assignments. Yet these are
still primarily manual scheduling techniques or
communication methods that are time consuming,
especially for supervisors. Lean labs initiatives, as
written by other writers previously mentioned, have
helped simplify the lab scheduling process, but do not
offer a robust and computerized scheduling solution.
As a result, lab scheduling heavily relies on the
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supervisor knowledge and experience to manage the
schedule of his/her team (Maslaton, 2012b). For this
reason, Westgard (1996) found it necessary for QC
managers to continuously improve their analytical
quality management skills.
Alternatively, De Wit (2011) realized that scheduling
was more effective and successful if analyst teams
were allowed to also participate in planning,
scheduling and organizing their individual workflows.
They can then operate as if they're running their own
business by scheduling their work. Analysts know
what is coming in and are able to organize workflow
without the involvement of a supervisor. As teams,
they will be able to discuss, review and rectify issues
(DeWit, 2011).
Resource scheduling is the strategic level for QC
operations, while resource modelling is the first step
in planning. Creating yearly budgets can be stressful.
There will be pressure to cut buying, costs and
reducing staff while improvements in service levels
will still be expected. That is when Lean Six Sigma
approaches fall short due to complexities of the lab.
Laboratory managers face the challenges of building
a team comprised of the right number of analysts and
ensuring that the available equipment is sufficient to
process incoming samples within reasonable
turnaround times (Lopes et al., 2018). Labour is the
single largest expense in the QC lab, as the analysts
and chemists are relatively highly paid compared to
the manufacturing operators. Therefore, it would be
beneficial to have an advanced modelling tool to
accurately project the number of people needed to
support the business based on a given forecast
(Maslaton, 2012a). Too many analysts will increase
costs leading to less funds available to invest in other
quality activities and more expensive drugs. On the
other hand, too few analysts lead to increase in
overtime costs, stress, inefficiencies and inability to
consistently deliver drugs to patients in a timely
manner.
In 1984, a computer simulation model based on
queueing theory was designed by quality control
laboratories, demonstrating that the queuing theory
is applicable to existing laboratory organisations.
Descriptions of the sample input and the existing work
capacity of the laboratory, along with the relationships
between batch intake and batch processing of
samples, were the critical parameters.
Through a number of simulation experiments, it was
demonstrated that
investigating organizational
features can lead to enhanced performance with an
increased yield of analytical information (Janse &
Kateman, 1984)

Klaessens et. al. (1988) were one of the early
research collaborations to establish a model for the
QC lab. They presented a decision support system,
which e=they called LABGEN, by means of digital
simulation. The system
constructed simulation
models of laboratory organizations by combining
historical data with a rule-based framework compiled
from expert knowledge to derive, test and compare
laboratory organization structures in an interactive
manner (Klaessens et al., 1988).
Ruiz-Torres et al. (2012) modelled a software
prototype to address the complex scheduling
problems, which was faced in a pharmaceutical
industry QC lab setting, with implemented solution
algorithms. Focusing mainly on the pharmaceutical
industry, their problem dealt with assigning jobs to
analysts as part of the quality control phase in order
to minimise the total turnaround time and the number
of tasks not meeting a required timeline.
Considerations included overlapping tests, test
batching,
overlapping
tests
and
resource
assignments constrained by test specific capability
requirements. It was noted that similar tasks could be
put in a batch. However, batch sizes would differ
depending on the product-test type combination. This
marked a significant difference from previous
literature in batching parallel machines (Ruiz-Torres
et al., 2012).
Realizing that even though a good planning or
scheduling system may be put into place, analyst
competency may hinder their success. Ruiz-Torres et
al. (2017) conducted another study on assignment of
technicians to quality control tests in QC lab of the
pharmaceutical manufacturing environment. The
problem focused on constraints related to the
capabilities of the analysts/ technicians, as well as
various criteria related to efficiency, customer service
and worker satisfaction. An analyst/technician
satisfaction metric and a heuristic were utilized to
maximize this measure (Ruiz-Torres et al., 2017)..
Lopes et. al, building on Maslaton’s research, realized
that the lab resources, including both analysts and
equipment, required consideration as samples of
several types had to be tested. These samples
included raw materials, intermediates and final
products, in-process control samples, cleaning
validation samples and stability samples, among
others. The different samples could be categorized
into different priority degrees (Lopes et.al., 2018).
Lopes et al. structured regime fails to capitalize on
possible benefits that a free-for-all approach could
entail. This was based on the understanding that the
pool of resources could theoretically be shared
between branches, as the analysts share the same
qualifications, certifications and competences thus
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can operate contiguously under proprietary resource
allocation policies. They built a simulation model of a
pharmaceutical QC lab to be employed as a
benchmarking platform to estimate the performance
of a new facility under alternative governance models.

TYPES OF PRODUCTS MANUCTURED BY
XYZ

Lopes et al.’s approach was devised to assess the
impact of (1) different branches, (2) different analyst
schedule configurations and (3) high-level sample
allocation and scheduling policies on system
performance under the two governance models
(structured vs. free-for-all). The Discrete Event
Systems (Cassandras & Lafortune, 2009) was then
used as the methodology of choice to model quality
control laboratories for simulation purposes. The
discrete event simulation paradigm was implemented
in modern commercial software that was based on the
definition of entities that flowed through the system
along the steps of an underlying logic framework.
Under that agent-based structure, and taking QC
laboratories into context, samples were modelled as
entities, while equipment and analysts were treated
as resources (Lopes et al., 2018).

Antitubercular

Schäfer (2004) agreed with many researchers on the
importance of scheduling and planning. He
highlighted that the different modeling tools
researchers were establishing needed to rely on
concepts
building
a
consistent
framework.
Components of the different modeling tools included
samples, devices, sensors, results, database systems
etc, He, therefore, defined a set of terms and
definitions used in a dynamic scheduling
environment. In detail, he described the entities,
including their functionality, and attributes, as well as
their logical and physical interactions. Concepts such
as functional libraries, dynamic execution, workflows
with activities and constraints and hidden transport
were also described. He did not leave out calibration,
maintenance, error management and discussion of
how the entities interacted with the different
components in the scheduling systems (Schäfer,
2004).
According to Maslaton (2012a), the key to imodelling
in QC was simplifying the lab’s complexity, while
maintaining the desired level of accuracy. However,
though it is tempting to collect 12 months data via time
studies, this trap should be avoided as it is timeconsuming yet not beneficial.
The aim of this study, in the QC lab at XYZ
Pharmaceuticals, was to demonstrate whether an
efficient resource modelling tool can be developed in
a shorter period.

Antibiotics

Antifungals
Analgesics/Antipyretics
NSAIDs
Xanthine Oxidase Inhibitors
Antihistamines
Antiamoebics
Diuretics
Antacids
Anti-ulcer
Antiepileptics
Antivirals
Cough and Cold Remedies
Antidiabetics
Antivirals

Table 1 shows the different categories of medicines
manufactured by XYZ Pharmaceuticals.

2. METHODS
The following methodology, to come up with a
resource modelling tool for the QC lab at XYZ
Pharmaceuticals, was implemented:
A. Three main product families were
identified:
1.

Table 1. Products Manufactured by XYZ.

Reviewed updated product list
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2.
Defined product families based on
similarities in testing

B.
Bills of tests for each product family
were generated.
1.
Test procedures of random 10
products in each family were reviewed.
2.
Bills of tests for each family that
included all tests applicable to it were
compiled.

Table 2: Maslaton’s Model Assumptions
Key Assumption – On average, 30% of analyst
time is spent on non-testing activities such as
data monitoring/trending, calibrations, glassware
cleaning, instrument troubleshooting, collecting
reference standards, etc.
Other assumptions – two weeks plant shut
down, three weeks of vacation and leave days,
one-week public holidays, six weeks spent on
non-testing activities (i.e. calibration, collecting
reagents, investigation etc.)

C.
Forms for each family with bills of
tests were created and issued to analysts.
D.
For a period of 30 days, the Chief
Chemist who is the supervisor, would give
analysts a form for the family type of sample
he would have issued to them for testing.
E.
•

3. RESULTS AND DISCUSSION
RESULTS
Table 3: Product Families

Analysts filled in:

IDENTIFIED PRODUCT FAMILIES

the hands on times to test samples
of products from the different
families.

Tablets/Capsules

- Family A

Syrups/Suspensions

- Family B

Creams/Ointments

- Family C

This included times to do each test as per the
product’s pharmacopoeial specifications. Average
times for each test/activity were determined.
F.
Total hands on time (HOTT) for each
family was determined by adding the
average times taken to conduct all tests
such as. hardness test, disintegration test
etc, of the product representing the family,
as per its pharmacopoeial specifications.
Overall total hands on time (OHOTT) in a
year was calculated by multiplying factored
HOTT of the different product families by the
average batches manufactured annually
based on historical data. The factors were
derived from dividing the number of products
in a particular family by the total of the
company’s product portfolio.
G.
The total number of analysts
required to handle the current workload was
calculated using Maslaton’s model
(Maslaton, 2012). The following assumptions
and rules were taken into consideration (see
Table 2).

A total of 39 finished product samples was tested
during the period under the study. 16 were in family
A, 13 in family B and ten in family C.

7
FAMILY A

FAMILY B

Table 4: Tablets/Capsules HOTs (Hours) – Hands on
time calculated for measuring qualities of
Tablets/Capsules.

Test

HOT

APPEARANCE

0.083

Table 5: Syrups/Suspensions HOTs (Hours)

APPEARANCE

0.083

pH at 25°C

0.083

IDENTIFICATION

0.25

SPECIFIC GRAVITY

DISINTEGRATION TIME

0.25

IDENTIFICATION

THICKNESS

0.167

ASSAY

DIAMETER

0.167

REPORT WRITING

0.25
1
1.5
1

TOTAL HOT
UNIFORMITY OF WEIGHT

0.2

MOISTURE CONTENT

0.25

HARDNESS

0.167

FRIABILITY

0.167

DISSOLUTION

2

ASSAY

2

RELATED SUBSTANCES

6

CONTENT UNIFORMITY

4

TOTAL HOT

15.701

Fig 1: Family A HOTs

Tablets/Capsules HOTs (hrs)

TOTAL HOT
CONTENT UNIFORMITY
ASSAY
FRIABILITY
MOISTURE CONTENT
DIAMETER
DISINTEGRATION TIME
APPEARANCE

0.

3.916

4.

8.

12. 16. 20.

Fig 2: Family B HOTs

Syrups/Suspensions HOTs
(hrs)

TOTAL HOT
REPORT WRITING
ASSAY
IDENTIFICATION
SPECIFIC GRAVITY
pH at 25°C

0.

1.

2.

3.

4.

5.
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FAMILY C
Table 6: Creams/Ointments HOTs (Hours)

APPEARANCE

Fig 4: Comparison of families Total HOTs

0.083

IDENTIFICATION

1.33

pH (AT 25 oC)

0.25

SPREADABILITY

0.75

PRESERVATIVE

2.5

ASSAY

3

RELATED SUBSTANCES

4

REPORT WRITING

1

TOTAL HOT

TOTAL HOT (HOURS) per
family

FAMILY C

FAMILY B

FAMILY A

12.91

3.92
0.

4.

8.

12.

15.7

16.

20.

Table 8 – Number of products in each family

12.913

PRODUCT TYPE

NO. OF PRODUCTS FACTOR

Fig 3: Family C HOTs

Creams/Ointments HOTs
(hrs)
TOTAL HOT

RELATED SUBSTANCES

85 0.691057

FAMILY B

26 0.211382

FAMILY C

12 0.097561

TOTAL

PRESERVATIVE
pH (AT 25 oC)

APPEARANCE

FAMILY A

123

Fig 5: Number of products in each family

0.

3.5

7.

10.5

Products in each
C
family

14.

10%

SUMMARIES
Table 7 –Total Hands on Time for the identified three
product families

PRODUCT FAMILY

HOTT (HOURS)

TABLETS AND CAPSULES

15.7

SYRUPS AND
SUSPENSIONS

3.92

CREAMS AND OINTMENTS

B
21%

12.91

A
69%

1
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THE CALCULATION MODEL
Fig 6: Calculation Model

CALCULATION MODEL
52 weeks * 43.75 hours (8.75 hours per day excluding breaks * 5 days a week) – 12 weeks
(analysts unavailable for testing) * 43.75
= 1750 hours
Overall Hands on Time (OHOTT) for one year
(0.2*3.92) + (0.11*12.91))*500 (batches manufactured per year)
= 6473.6 hours

= ((0.69*15.7) +

Analysts required for finished products bench testing = (OHOTT) per period / Total working time
per period
= 6473.6 hours / 1750 hours
= 4.81
i.e. 5 analysts

Using the HOTs of the different families, product
type factors presented in Table 7 and indicated
assumptions, the number of analysts required for
routine testing of finished products samples was
found to be five.

DISCUSSION
Based on data analysis using data limited to 30
days, this study showed that five analysts are
required for bench testing of finished product for the
QC demand at XYZ Pharmaceuticals. It would be
useful for the QC team of XYZ Pharmaceuticals to
continue the study by comparing data collected in
the previous three to six months to fully validate the
model. The samples and their type factors will be
input to the model as forecast and running
calculation will give the required number of analysts
for the period. If the result matches within +/- 10%
to the actual number of resources (i.e. analysts who
tested the samples in those periods), the model can
be adopted as is. Thus, the lab resources can be
declared successfully modelled. It is however,
important to factor vacations, overtime, etc. during
the periods by adding or subtracting. For instance, if
15% overtime was experienced, resources should
be normalised by the same factor (Maslaton, 2012).
If the results are found to be too high, it may mean
estimates were too relaxed maybe HOTs for
example, or certain activities were double-counted
therefore review and an investigation will be
necessary. On the contrary, extreme differences; for

example if a result of 30 analysts was found from
the calculation, and yet in reality 60 analysts had
done the work in the chosen period, may mean
estimates were too aggressive or some work was
missed (Maslaton, 2012).
Once results are established within -/+ 10%, this
can be the baseline model. If a company is still
interested in conducting full-time studies, they can
move forward since grouping and forecast would
have been done, focusing on bigger issues such as
the highest contributing tests to overall
staffing/instrument requirements (Maslaton, 2012).
It will be normal to question the benefits from such a
model, considering complexities of the lab and
significant effort that would be required to build a
resource model tool other than estimating number
of analysts or instruments in the lab. There are
many other opportunities for improvement that can
be used to refine strategies and accustomed
operating models, such as:
-

identify tests with most HOT/FTE;

-

identify desired campaign size
method/product;

-

identify ROI for projects leveraging the
standards that were collected for
scheduling, costing and efficiency
calculation;

-

define training road map based on HOTs for
each method;

-

establish campaign size for analyst;
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-

through the estimates for given periods, reprioritize projects in the lab to meet the
desired service level for estimated demand;

-

use Lean and Six Sigma to reduce HOTs;

-

limit vacations during certain periods etc.;

-

refine KPIs (Maslaton, 2012).

4. CONCLUSION
This model is important for companies as it helps
them determine the human resources they require
to efficiently operate a QC laboratory, in a short
period. Time and resources that would otherwise
be wasted on conducting are saved. The model can
also be easily implemented.

5. RECOMMENDATIONS FOR NEXT
STEPS
The study will be benchmarked by another of XYZ’s
R&D QC Laboratory as one of the validation tools.
Other pharmaceutical QC laboratories are
encouraged to benchmark this study to validate and
improve the model internationally. This would
strengthen the case study as a template that can be
used confidently by other QC laboratories.
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